Biyao Xie

Biyao Xie

Auto-generated profile, based on publicly available information

Biyao Xie

Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, Shantou 515041, China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
YLYingjia Lin
Yingjia Lin
SKShuping Ke
Shuping Ke
WYWeiqing Ye
Weiqing Ye
BXBiyao Xie
Biyao Xie
ZHZijing Huang
Zijing Huang
Diabetic retinopathy (DR) remains the leading cause of blindness among the global working-age population. Emerging evidence underscores the significance of diabetic retinal neurodegeneration (DRN) as a pivotal biomarker in the progression of vasculopathy. Inflammation, oxidative stress, neural cell death, and the reduction in neurotrophic factors are the key determinants in the pathophysiology of DRN. Non-apoptotic programmed cell death (PCD) plays a crucial role in regulating stress response, inflammation, and disease management. Therapeutic modalities targeting PCD have shown promising potential for mitigating DRN. In this review, we highlight recent advances in identifying the role of various PCD types in DRN, with specific emphasis on necroptosis, pyroptosis, ferroptosis, parthanatos, and the more recently characterized PANoptosis. In addition, the therapeutic agents aimed at the regulation of PCD for addressing DRN are discussed.